Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Clinical characteristics … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Clinical characteristics at implants with a history of progressive bone loss.

Artikel i vetenskaplig tidskrift
Författare Christer Fransson
Jan Wennström
Tord Berglundh
Publicerad i Clinical oral implants research
Volym 19
Nummer/häfte 2
Sidor 142-7
ISSN 0905-7161
Publiceringsår 2008
Publicerad vid Institutionen för odontologi
Sidor 142-7
Språk en
Länkar dx.doi.org/10.1111/j.1600-0501.2007...
Ämnesord dental implants, complications, bone loss, human, smoking
Ämneskategorier Biomaterial

Sammanfattning

Objective: The aim of the present study was to describe the clinical characteristics at implants with a history of progressive bone loss. Material and methods: Eighty-two out of 184 previously identified subjects with a history of progressive bone loss volunteered for the study. Clinical assessments of plaque, bleeding on probing (BoP), probing pocket depth (PPD), suppuration following probing (Pus), presence of calculus on implants surfaces (Calc) and 'recession' i.e. the mucosal margin in level with or apical of the fixture/abutment junction were performed at the mesial, distal, buccal and lingual aspects of each implant and without removing the bridge constructions. Results: It was demonstrated that the frequencies of BoP, Pus, 'recession' and PPD>/=6 mm were higher at implants with than without 'progressive' bone loss. In addition, smokers had larger numbers of affected implants than non-smokers, and the proportion of affected implants that exhibited Pus and PPD>/=6 mm was higher in smokers than in non-smokers. The logistic regression analysis revealed that the findings of Pus, 'recession' and PPD>/=6 mm at an implant in a smoking subject had a 69% accuracy in identifying the history of progressive bone loss. Conclusion: The results from this study demonstrate an association between clinical signs of pathology and bone loss at implants. It is recommended to include clinical assessments in the evaluation of implant therapy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?